drugset / Trial / NCT01704001

Clinical Pharmacokinetics Study of ART-123 in Disseminated Intravascular Coagulation (DIC) Subjects With Renal Impairment

NCT01704001 ↗

Phase 4 Completed 40 enrolled Asahi Kasei Therapeutics Corporation
Non-randomizedParallel-groupOpen-labelTreatment

Summary

To investigate the impact of impaired renal function on the pharmacokinetics of ART-123 in patients with Disseminated Intravascular Coagulation. To investigate the safety of ART-123 in patients with Disseminated Intravascular Coagulation.

Timeline

Start
2012-10
Primary completion
2013-10
Completion
2014-06

Drugs

EvaluationDrugModalityDoseRoute
Subject thrombomodulin alfa Protein / enzyme biologic 130 iu/kg —
Subject thrombomodulin alfa Protein / enzyme biologic 380 iu/kg —